PROVIDER PROFILE · NPI 1992192843
Bahar MoftakharM.D.
PRESCRIBING · PART D · 2024
Total Rx claims
659
Beneficiaries
—
Total drug cost
$1.5M
Distinct drugs
11
Brand share
14.4%
Top prescribed drugs
Anastrozole388 claims
Ribociclib Succinate59 claims
Letrozole52 claims
Ondansetron Hcl32 claims
Exemestane30 claims
QUALITY · MIPS · 2024
Final MIPS score
81.2
Quality
63.1
Cost
74.2
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.26%
Group
CROSS-REFERENCE